BackOutlook Therapeutics- Warrants Overview
Outlook Therapeutics Inc - Warrants - Series A (18/02/2022)

Outlook Therapeutics- Warrants P/E Ratio

Price-to-Earnings ratio for OTLKW.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

-0.98

P/E Ratio

-0.98

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

Average P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading